<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/wp-content/plugins/xml-sitemap-feed/assets/sitemap-news.xsl?ver=5.7.7"?>
<!-- generated-on="2026-07-17T19:31:43+00:00" -->
<!-- generator="XML Sitemap & Google News for WordPress" -->
<!-- generator-url="https://status301.net/wordpress-plugins/xml-sitemap-feed/" -->
<!-- generator-version="5.7.7" -->
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" >
<url><loc>https://diabeticinsieme.it/fda-avvertimento-abbott-beta-bionics-dispositivi-diabete/</loc><news:news><news:publication><news:name>Diabetic Insieme</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-07-17T20:04:41+02:00</news:publication_date><news:title>Dispositivi per il diabete sotto la lente della FDA, avvertimento ad Abbott e Beta Bionics</news:title></news:news></url>
<url><loc>https://diabeticinsieme.it/giuseppe-maltese-diabete-fragilita-anziano-londra/</loc><news:news><news:publication><news:name>Diabetic Insieme</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-07-17T20:04:15+02:00</news:publication_date><news:title>Diabete e fragilità nell&#8217;anziano, la ricerca di Giuseppe Maltese al King&#8217;s College London</news:title></news:news></url>
<url><loc>https://diabeticinsieme.it/microinfusori-tubeless-beta-bionics-tandem-insulet/</loc><news:news><news:publication><news:name>Diabetic Insieme</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-07-17T20:03:50+02:00</news:publication_date><news:title>Microinfusori tubeless, Beta Bionics e Tandem annunciano la sfida a Insulet nel mercato cerotto</news:title></news:news></url>
<url><loc>https://diabeticinsieme.it/prediabete-reversibile-perseghin-finestra-intervento/</loc><news:news><news:publication><news:name>Diabetic Insieme</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-07-17T20:03:20+02:00</news:publication_date><news:title>Prediabete reversibile, il professor Perseghin indica la finestra d’intervento prima che il danno si consolidi</news:title></news:news></url>
<url><loc>https://diabeticinsieme.it/diabete-tipo-2-indagine-fiaso-ssn-bari/</loc><news:news><news:publication><news:name>Diabetic Insieme</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-07-17T19:37:03+02:00</news:publication_date><news:title>Assistenza al diabete di tipo 2, da Bari parte l&#8217;indagine Fiaso sul Servizio sanitario</news:title></news:news></url>
<url><loc>https://diabeticinsieme.it/prevenzione-diabete-tipo-2-linee-guida-ada-dieta/</loc><news:news><news:publication><news:name>Diabetic Insieme</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-07-17T19:32:20+02:00</news:publication_date><news:title>Prevenire il diabete di tipo 2, le linee guida ADA 2026 premiano dieta mediterranea e low-carb</news:title></news:news></url>
<url><loc>https://diabeticinsieme.it/pivot-microinfusore-insulina-tubeless-stati-uniti/</loc><news:news><news:publication><news:name>Diabetic Insieme</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-07-17T19:31:55+02:00</news:publication_date><news:title>Pivot, il microinfusore di insulina a cerotto senza tubi debutta negli Stati Uniti</news:title></news:news></url>
<url><loc>https://diabeticinsieme.it/irisina-beta-cellule-diabete-tipo-2-studio-bari/</loc><news:news><news:publication><news:name>Diabetic Insieme</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-07-17T19:30:41+02:00</news:publication_date><news:title>Diabete di tipo 2, l&#8217;irisina dei muscoli recupera la funzione delle beta-cellule</news:title></news:news></url>
</urlset>
